EGFR and HER2 are the most recognized tyrosine kinase receptors in gastric cancer [4], while overexpression of other recognized tyrosine kinase receptors in gastric cancers includes fibroblast growth factor receptor 2 (FGFR2) and MET [5,6]. The gene discussed is MET; the disease is gastric cancer.